These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11490284)

  • 21. Erectile and urinary dysfunction after radical prostatectomy for prostate cancer in Quebec: a population-based study of 2415 men.
    Karakiewicz PI; Tanguay S; Kattan MW; Elhilali MM; Aprikian AG
    Eur Urol; 2004 Aug; 46(2):188-94. PubMed ID: 15245812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can erectile function be predicted after prostate cancer treatment?
    Alba FM; Wang R
    Asian J Androl; 2012 Jan; 14(1):134-5. PubMed ID: 22080916
    [No Abstract]   [Full Text] [Related]  

  • 23. Complications from treatment for prostate carcinoma among men in the Detroit area.
    Schwartz K; Bunner S; Bearer R; Severson RK
    Cancer; 2002 Jul; 95(1):82-9. PubMed ID: 12115320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.
    Glickman L; Godoy G; Lepor H
    J Urol; 2009 Feb; 181(2):731-5. PubMed ID: 19091349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance K. Fujika, P. Landis, B. K. McNeil and C. P. Pavlovich J Urol 2009; 182: 2664-2669.
    Atan A; Tuncel A
    J Urol; 2010 Jun; 183(6):2471-2. PubMed ID: 20416896
    [No Abstract]   [Full Text] [Related]  

  • 26. [Surgery of prostate cancer].
    Villers A; Rébillard X
    Rev Prat; 2003 Dec; 53(20):2246-52. PubMed ID: 15018078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential treatment for recurrent localized prostate cancer.
    Van Der Poel HG; Moonen L; Horenblas S
    J Surg Oncol; 2008 Apr; 97(5):377-82. PubMed ID: 18360820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sexual foreplay incontinence in men with erectile dysfunction after radical prostatectomy: a clinical observation.
    Guay A; Seftel AD
    Int J Impot Res; 2008; 20(2):199-201. PubMed ID: 18200019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preserving potency after prostate cancer surgery.
    Harv Mens Health Watch; 2002 Sep; 7(2):7-8. PubMed ID: 12356553
    [No Abstract]   [Full Text] [Related]  

  • 31. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    Lehrer S; Cesaretti J; Stone NN; Stock RG
    BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conventional treatments of localized prostate cancer.
    Zerbib M; Zelefsky MJ; Higano CS; Carroll PR
    Urology; 2008 Dec; 72(6 Suppl):S25-35. PubMed ID: 19095125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local recurrence after primary therapy for clinically localized prostate cancer: is radiation or surgery "Better" in the salvage setting?
    Wood CG
    J Surg Oncol; 2008 Apr; 97(5):376. PubMed ID: 18360819
    [No Abstract]   [Full Text] [Related]  

  • 34. Sexual dysfunction in men with prostate cancer: psychosocial issues.
    J Support Oncol; 2007 Feb; 5(2):91-2. PubMed ID: 17348371
    [No Abstract]   [Full Text] [Related]  

  • 35. Prostate cancer surgery: is nerve-sparing safe?
    Harv Mens Health Watch; 2005 Feb; 9(7):4-7. PubMed ID: 15799105
    [No Abstract]   [Full Text] [Related]  

  • 36. The psychosocial aspects of sexual recovery after prostate cancer treatment.
    Wittmann D; Northouse L; Foley S; Gilbert S; Wood DP; Balon R; Montie JE
    Int J Impot Res; 2009; 21(2):99-106. PubMed ID: 19158798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cavernous nerve reconstruction to restore erectile function following radical prostatectomy].
    Song LJ; Pan LJ; Xu YM
    Zhonghua Nan Ke Xue; 2006 Oct; 12(10):939-42. PubMed ID: 17121030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
    Bradley EB; Bissonette EA; Theodorescu D
    BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time course and predictors of symptoms after primary prostate cancer therapy.
    Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
    J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re: Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.
    Dalkin BL
    J Natl Cancer Inst; 2001 Mar; 93(5):401-2. PubMed ID: 11238710
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.